Northwell Health

Great Neck, New York 11030

9 studies enrolling now · 62 studies all time

What they study most

Active Idiopathic Inflammatory Myopathy, Active Refractory Rheumatoid Arthritis, Acute Kidney Injury, Alcohol Abuse, Alcohol Drinking, Alcohol Use Disorders, Alcohol-Related Disorders, Alcoholism, Antineutrophil Cytoplasmic Antibody-associated Vasculitis, Antisynthetase Syndrome, Arrhythmia, Arthritis, Rheumatoid

Studies at this site

• A Phase 2 Master Protocol Assessing Inebilizumab and Blinatumomab in Autoimmune Diseases — Recruiting now
• A Study to Test Whether Nerandomilast Helps People With Lungfibrosis Related to Rheumatic Diseases — Recruiting now
• Phase 2b Study of RPT904 as Monotherapy in Participants With IgE-Mediated Food Allergy — Recruiting now
• A Study to Evaluate Avacopan in Participants With ANCA-associated Vasculitis — Recruiting now
• Daratumumab in Primary Antiphospholipid Syndrome — Recruiting now
• Platform Clinical Study for Conquering Scleroderma — Recruiting now
• Nafamostat Efficacy in Phase 3 Registrational CRRT Study — Recruiting now
• Perioperative Anticoagulant Use for Surgery Evaluation -Virtual Visit (PAUSE-Virtual) — Recruiting now
• A Study to Investigate the Efficacy and Safety of Efgartigimod PH20 SC in Adult Participants With Active Idiopathic Inflammatory Myopathy. — Completed
• A Study to Evaluate the Efficacy, Safety and Pharmacokinetics (PK) of a Higher Dose of Ocrelizumab in Adults With Primary Progressive Multiple Sclerosis (PPMS) — Running, not enrolling
• Study Assessing Long-teRm Outcomes of dupiluMAb (DUPIXENT®) Treatment in Adult Patients With Chronic Rhinosinusitis With Nasal Polyposis (CRSwNP) — Running, not enrolling
• A Study of Combination Therapy With Guselkumab and Golimumab in Participants With Moderately to Severely Active Crohn's Disease — Running, not enrolling
• A Study to Learn How Well Dupilumab Works in Adult and Adolescent Participants With Eosinophilic Gastritis With or Without Eosinophilic Duodenitis and the Side Effects it May Have — Running, not enrolling
• Study to Determine if BHV-7000 is Effective and Safe in Adults With Refractory Focal Onset Epilepsy — Running, not enrolling
• Trial of Parkinson's And Zoledronic Acid — Completed
• Wearable Assessments in the Clinic and Home in PD — Completed
• A Maintenance Study of Mirikizumab in Participants With Moderately to Severely Active Ulcerative Colitis — Completed
• Peanut Sublingual Immunotherapy (SLIT)-Tablet for Treatment of Peanut Allergy — Completed
• Long-term Safety and Tolerability of BHV-7000 — Enrolling by invitation
• A Study to Assess the Long-term Safety and Efficacy of ATB200/AT2221 in Adult Subjects With Late-Onset Pompe Disease (LOPD) — Completed
• A Study of Olezarsen (ISIS 678354) Administered to Participants With Severe Hypertriglyceridemia — Completed
• A Study About How TAK-881 is Processed by the Body and Side Effects in People With Primary Immunodeficiency Diseases — Completed
• ReActiv8 Stimulation Therapy vs Optimal Medical Management: A Randomized Evaluation — Completed
• A Study of KZR-616 in Patients With SLE With and Without Lupus Nephritis — Completed
• KYSA-1: A Study of Anti-CD19 Chimeric Antigen Receptor T-Cell (CD19 CAR T) Therapy, in Subjects With Refractory Lupus Nephritis — Running, not enrolling
• Dose Finding, Efficacy and Safety of BI 655064 in Patients With Active Lupus Nephritis — Completed
• KYSA-5: A Study of Anti-CD19 Chimeric Antigen Receptor T-Cell (CD19 CAR T) Therapy, in Subjects With Systemic Sclerosis — Running, not enrolling
• Study of Anti-Malarials in Incomplete Lupus Erythematosus — Completed
• Evaluation of the Personal KinetiGraph™ (PKG™) to Improve Insight Into Parkinson's Disease Status — Running, not enrolling
• STRIDE Study - A Study in Subjects With LOPD Who Are Currently Being Treated With ERT — Stopped early
• Strategy to Prevent the Onset of Clinically-Apparent Rheumatoid Arthritis — Stopped early
• An Induction Study of Mirikizumab in Participants With Moderately to Severely Active Ulcerative Colitis (LUCENT 1) — Completed
• Long Term Extension of Safety and Efficacy of Vagus Nerve Stimulator in Patients With Rheumatoid Arthritis (RA) — Running, not enrolling
• Transcendental Meditation in Veterans and First Responders With PTSD — Stopped early
• Zoster Eye Disease Study — Completed
• Stereotactic Laser Ablation for Temporal Lobe Epilepsy (Slate) — Completed
• Entyvio (Vedolizumab) Long Term Safety Study — Completed
• A Study of LY3471851 in Adults With Systemic Lupus Erythematosus (SLE) — Completed
• A Study to Evaluate the Safety, Pharmacokinetics (PK), and Pharmacodynamics (PD) of TAK-079 in Combination With Standard Background Therapy in Participants With Moderate to Severe Systemic Lupus Erythematosus (SLE) — Completed
• Computational Modeling of 60 Hz Subthalamic Nucleus Deep Brain Stimulation for Gait Disorder in Parkinson's Disease — Completed
• Validation of a Mobile Phone Based on EPRO Tool in Subjects With Systemic Lupus Erythematosus — Completed
• Collaborative Care for Alcohol Use Disorders in the Patient-centered Medical Home — Completed
• Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Immunogenicity of Efavaleukin Alfa in Participants With Systemic Lupus Erythematosus — Completed
• Study to Evaluate the Efficacy of Tenapanor as Adjunctive Therapy to Phosphate Binder Therapy — Completed
• Study to Determine the Safety and the Efficacy of Fasinumab Compared to Placebo and Nonsteroidal Anti-inflammatory Drugs (NSAIDs) for Treatment of Adults With Pain From Osteoarthritis of the Knee or Hip — Completed
• A Study of Baricitinib (LY3009104) in Participants With Systemic Lupus Erythematosus — Stopped early
• Treatments Against RA and Effect on FDG-PET/CT — Completed
• Take a Break (TAB): mHealth-assisted Skills Building Challenge for Unmotivated Smokers — Completed
• An Exploratory Maintenance Trial of BI 655064 in Patients With Lupus Nephritis — Completed
• An Extension Study of Omalizumab in Participants With Chronic Rhinosinusitis With Nasal Polyps — Completed